Brexpiprazole

What is Brexpiprazole?

Brexpiprazole is an atypical antipsychotic medication, known by its brand name Rexulti, used to treat certain mental health conditions. Approved by the U.S. FDA in 2015, it belongs to a class of drugs that manage psychiatric disorder symptoms by affecting brain neurotransmitters. Unlike older antipsychotics, atypical antipsychotics often present a different side effect profile, potentially with a lower risk of specific motor side effects. Brexpiprazole is taken orally, typically once daily, and is a key treatment for conditions like schizophrenia and major depressive disorder. Understanding its properties, uses, and potential effects is vital for patients and healthcare providers alike.

How Does it Work?

The mechanism of action for Brexpiprazole is intricate, involving its role as a serotonin-dopamine activity modulator. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and an antagonist at serotonin 5-HT2A and noradrenaline alpha1B/2C receptors. This unique pharmacological profile helps stabilize dopaminergic and serotonergic systems, which are often dysregulated in conditions such as schizophrenia and depression. Antagonism at 5-HT2A receptors is particularly important for its antipsychotic effects, potentially leading to fewer extrapyramidal symptoms. This multifaceted action allows Brexpiprazole to address various symptoms, including positive symptoms in schizophrenia and mood-related symptoms in major depressive disorder.

Medical Uses

Brexpiprazole is indicated for two primary conditions:

• Schizophrenia: It is approved for adult schizophrenia, a chronic mental disorder affecting thought, feeling, and behavior. Brexpiprazole helps reduce symptoms like hallucinations and delusions, improving patient functioning.
• Adjunctive Treatment for Major Depressive Disorder (MDD): It serves as an add-on therapy to antidepressants for adults with Major Depressive Disorder. When standard antidepressants alone are insufficient, adding Brexpiprazole can further alleviate depressive symptoms in patients who haven't responded adequately to monotherapy.

Brexpiprazole should always be part of a comprehensive treatment plan, potentially including psychotherapy. It is not recommended for elderly patients with dementia-related psychosis due to increased mortality risk.

Dosage

The dosage of Brexpiprazole varies by condition and individual patient response. It's typically administered orally once daily, with or without food.

• For Schizophrenia: Start with 1 mg once daily, titrating to a target of 2 mg to 4 mg once daily. Max is 4 mg/day. Adjustments are weekly in 0.5 mg or 1 mg increments.
• For Adjunctive Treatment of Major Depressive Disorder: Start with 0.5 mg once daily, titrating to a target of 1 mg or 2 mg once daily. Max is 3 mg/day. Adjustments are weekly in 0.5 mg or 1 mg increments.

Patients must follow their healthcare provider's instructions. Do not stop Brexpiprazole abruptly to avoid withdrawal symptoms or symptom relapse. Missed doses should be taken as soon as remembered, unless close to the next dose.

Side Effects

Brexpiprazole can cause side effects. Common ones include:

• Akathisia: Inner restlessness and an urge to move.
• Weight gain
• Dizziness
• Nausea
• Diarrhea
• Headache
• Somnolence (sleepiness)

More serious, but less common, side effects include:

• Neuroleptic Malignant Syndrome (NMS): A severe reaction with high fever, muscle rigidity, and altered mental status.
• Tardive Dyskinesia: Involuntary movements, potentially irreversible.
• Metabolic Changes: Hyperglycemia, diabetes, dyslipidemia, and weight gain.
• Orthostatic Hypotension: Drop in blood pressure upon standing.
• Decreased white blood cell count (leukopenia, neutropenia, agranulocytosis).

Report any concerning symptoms to your doctor immediately.

Drug Interactions

Brexpiprazole can interact with other medications, altering its effects or increasing side effect risk. Inform your doctor about all medications and supplements.

Key interactions:

• CYP2D6 and CYP3A4 Inhibitors: Strong inhibitors (e.g., quinidine, ketoconazole) can increase Brexpiprazole levels, possibly requiring dose reduction.
• CYP3A4 Inducers: Strong inducers (e.g., rifampin, St. John's wort) can decrease Brexpiprazole levels, reducing effectiveness.
• CNS Depressants: Combining with alcohol or other CNS depressants (e.g., benzodiazepines) increases sedation and respiratory depression risk.
• Antihypertensive Agents: Caution is advised due to potential for orthostatic hypotension.

Always have a healthcare professional review your complete medication list for potential interactions.

FAQ

Q: What is the brand name for Brexpiprazole?

A: The most common brand name for Brexpiprazole is Rexulti.

Q: How long does it take for Brexpiprazole to work?

A: While some improvements may be seen within weeks, the full therapeutic effects of Brexpiprazole can take several weeks to appear. Consistent daily use is crucial.

Q: Can I stop taking Brexpiprazole if I feel better?

A: Never stop taking Brexpiprazole suddenly without consulting your doctor. Abrupt discontinuation can lead to withdrawal or relapse. Your doctor will guide safe tapering.

Q: Is Brexpiprazole a controlled substance?

A: No, Brexpiprazole is not classified as a controlled substance in the United States.

Products containing Brexpiprazole are available through trusted online pharmacies. You can browse Brexpiprazole-based medications at ShipperVIP or Medicenter.

Summary

Brexpiprazole is a vital atypical antipsychotic for schizophrenia and adjunctive treatment for major depressive disorder. Its unique serotonin-dopamine activity modulator mechanism effectively balances neurotransmitter activity. While generally well-tolerated, monitoring for side effects like akathisia, weight gain, and metabolic changes is crucial. Dosage requires careful titration under medical supervision, and awareness of drug interactions is important. Adherence to prescribed dosages and open communication with healthcare providers are key to maximizing benefits and minimizing risks. Brexpiprazole offers a valuable option for improving mental well-being and functional outcomes in severe mental health conditions.